The severity of airways obstruction as a determinant of treatment response in COPD.
about
Long-acting beta2-agonists for chronic obstructive pulmonary diseaseLong-acting inhaled therapy (beta-agonists, anticholinergics and steroids) for COPD: a network meta-analysisA score to predict short-term risk of COPD exacerbations (SCOPEX).Economic burden of asthma in Abu Dhabi: a retrospective studyChanging patterns in long-acting bronchodilator trials in chronic obstructive pulmonary diseasePredictors of pulmonary function response to treatment with salmeterol/fluticasone in patients with chronic obstructive pulmonary diseasePharmacological treatment response according to the severity of symptoms in patients with chronic obstructive pulmonary diseaseComparison and optimal use of fixed combinations in the management of COPD.Efficacy of salmeterol/fluticasone propionate by GOLD stage of chronic obstructive pulmonary disease: analysis from the randomised, placebo-controlled TORCH study.Efficacy and safety of indacaterol/glycopyrronium in Japanese patients with COPD: a subgroup analysis from the SHINE study.Salmeterol/fluticasone propionate combination in the treatment of COPD.
P2860
Q24197467-3B107337-E666-4859-98A0-782D1FD4D627Q24197853-8E433BA2-6164-4952-BF41-819724974A9DQ30619543-2D28651E-2ED5-4539-8862-AE535FB72A0BQ34393601-FD41944E-6562-4E95-ADD4-F889E5D6A5E6Q34554816-CDF172E9-BED7-455A-A3EC-6789274E8517Q34634754-8EAADA9E-4A34-446F-9D8C-62F9B4978BF9Q36254441-33AD92DC-C573-4659-AE33-02A312FA3B3EQ37017520-375AE048-DCA5-4F76-AF8B-158A7BDE335EQ37271761-0448F264-1A0D-49B1-826D-DE69F62779E6Q37344251-F48458E7-B9F9-44A8-BD29-DAA3A72271A5Q37754942-A90D6001-DCCF-43C1-BF27-4D2D3CE41A05
P2860
The severity of airways obstruction as a determinant of treatment response in COPD.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2006
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The severity of airways obstruction as a determinant of treatment response in COPD.
@en
The severity of airways obstruction as a determinant of treatment response in COPD.
@nl
type
label
The severity of airways obstruction as a determinant of treatment response in COPD.
@en
The severity of airways obstruction as a determinant of treatment response in COPD.
@nl
prefLabel
The severity of airways obstruction as a determinant of treatment response in COPD.
@en
The severity of airways obstruction as a determinant of treatment response in COPD.
@nl
P2093
P2860
P1476
The severity of airways obstruction as a determinant of treatment response in COPD.
@en
P2093
Julie A Anderson
Jørgen Vestbos
Paul W Jones
Peter Calverley
Romain A Pauwels
P2860
P304
P356
10.2147/COPD.2006.1.3.209
P407
P577
2006-01-01T00:00:00Z